qPCR and dPCR Instrumentation: Global Market Analysis, Trends, and Forecasts

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of the Study
qPCR
dPCR

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
Sizing the Market
Developing Countries Exude Tremendous Potential for Growth
qPCR Remains the Mainstay Technology
Research and Testing
Major Application Markets
Striking the Right Balance between qPCR and Dpcr in Research Laboratories
qPCR- A Suitable Tool for Gene Expression and Validation
A Peek into Select qPCR Systems Available in Marketplace
Thermo Fisher Life Sciences Prism 7000 Series
Thermo Fisher Life Sciences ViiA 7
Thermo Fisher Life Sciences QuantStudio
Cepheid SmartCycler Platform
Roche LightCycler Platform
Roche FLOW
As qPCR Technology Matures, Saturation is Imminent
Table 1: Global qPCR Instrumentation Market by Category (2017): Percentage Share Breakdown of Annual Revenues for Reagents and Instruments (includes corresponding Graph/Chart)
Digital PCR to Take Quantification of Nucleic Acids to the Next Level
dPCR
A Valuable Tool in Virology Research
High Sensitivity in Viral Detection
Creation and Validation of Viral Reference Standards
High-Precision Quantification
Sales of Digital PCR to Skyrocket in the Near Term
dPCR Holds Potential to Capture Application Markets from Predecessor Technologies
New dPCR Systems to Capture a Bigger Slice of the Market
Table 2: A Comparison of Select Leading dPCR Systems
QuantStudio 3D Digital PCR System
QuantStudio 12K
BioMark HD system
QX100 droplet digital PCR System
RainDrop Systems
High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
Despite Onslaught of Digital PCR, qPCR Maintains Relevance

2. GROWTH DRIVERS, MARKET TRENDS & ISSUES
Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
Table 3: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 4: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 5: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 6: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 7: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 8: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 9: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
Table 10: Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)
Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
Growing Prevalence of Genetic Disorders and Infectious Diseases Provide a Strong Case for Growth
Innovations in Instrumentation Expand Functionality and Drive Adoption
Adaptive PCR
A Recent Advancement
Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies
qPCR and NGS to Drive Single-Cell Genomics Market
Advancements in Probe Technology Enhance qPCR Sensitivity
qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
Factors influencing Selection of Lab Robots
Lab on Chip/Microfluidic Real-time-PCR
A Game Changer in the Offing
Two Types of Microfluidic Designs
Advantages of Lab on Chip PCR
Roadblocks in the Path to Development
New Developments in Lab-on-chip PCR
dPCR for Liquid Biopsies
Areas of Digital PCR has Immense Potential
ddPCR
The More Advanced Digital Approach to dPCR
Droplet digital PCR Finds Increasing Application in Life Sciences Research
ddPCR Gains Traction in Cancer Diagnosis
Monitoring Disease Progression in HIV Studies
Analysis of Genetically Modified Organisms in Edible Products
RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
Adoption of High Throughput Platforms Gains Pace
MC-ICP, A New Technique for Increasing Sensitivity of dPCR Instruments
Study Establishes High Reproducibility of dPCR
Clarity™ dPCR
An Advanced dPCR for Improved Workflows
Veterinary Diagnostic Applications Yet to Embrace dPCR
Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines
Alternate Technologies Pose Threat to Growth of PCR Market
New Isothermal PCR Technology
A Potential Game Changer Promising Faster PCR

3. COMPETITIVE LANDSCAPE
qPCR
A Highly Concentrated Market Place
Select qPCR Products by Company
Table 11: PCR Systems Product Portfolio of Thermo Fisher Life Sciences Solutions
Cost of PCR instruments and Reagents to Come Under Pressure
Competitive Landscape of dPCR Market
Bio-Rad Makes Rapid Strides in Life Science Arena with Two Big Deals
Qiagen Strengthens its Hold with Acquisitions
Intense Competition Triggers a Spate of M&A
Multiple Factors to Sustain Consolidation Trend in PCR Industry
Accelerated Commercialization of Products
Offering Integrated and Multi-technology Solutions
Manufacturers Step-Up Online Exposure
Manufacturers Target Expansion of Distribution Reach and Global Footprint

4. END-USE MARKET ANALYSIS
Application Areas of PCR
Medical and Diagnostics
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Detection of Antimicrobial Resistance
PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
Forensic and Paternity Testing
Food Safety
Detection and Quantification of Food Pathogens
Detection of Beneficial and Non-Pathogenic Microbes
Study of Microbial Responses to Environment
Microbial Risk Assessment
qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate
PCR Technique in Identification of GMOs
Research & Academics
SYBR Dye and TaqMan Techniques Popular in Research Publications

5. PRODUCT OVERVIEW
Introduction to Polymerase Chain Reaction (PCR)
Reagents and Components Required for PCR
Reaction Steps
Denaturation
Annealing
Extension
Real-Time PCR or Quantitative PCR (qPCR)
qPCR Instrumentation
Evolution
Working of qPCR Instruments
Thermal Control
Fluorimetry
DNA Detection Methods
Fluorescence Measurement
Asymmetrical dsDNA dyes
Quantification
High-Throughput qPCR
Comparison of Working of Conventional PCR versus qPCR
Drawbacks in Core PCR
Advantages of qPCR
Disadvantages of qPCR
End-Use Applications of qPCR
Factors Influencing Purchase Decisions of qPCR Systems
qPCR Consumables, Accessories and Software
DIGITAL PCR
Development of dPCR
Working Principle
Droplet dPCR
Applications of dPCR
Advantages of dPCR

6. PRODUCT INNOVATIONS/INTRODUCTIONS
Bio-Rad Rolls Out New RT-PCR Kit for Simultaneous Screening of Various Viruses
Agilent Technologies Launches AriaDx Real-Time PCR System
FORMULATRIX Introduces CONSTELLATION® Digital PCR System
Roche Rolls Out cobas® Liat® PCR System in Europe
Thermo Fisher Launches QuantStudio 5 RT PCR System
RainDance Introduces RainDrop Plus™ Digital PCR System
Stilla Launches Digital PCR System
Analytik Jena Unveils qTOWER³ RT PCR Thermal Cycler
Bio-Rad Rolls Out ddPCR™ Supermix
Takara Bio Unveils Thermal Cycler Dice® Real Time System III
Exiqon Introduces ExiLERATE LNA™ qPCR Reagents and Kits
Thermo Fisher Launches PowerUp SYBR Green PCR Master Mix
Thermo Fisher Introduces QuantStudio 3 and QuantStudio 5 RT PCR Systems
Kapa Biosystems Rolls Out KAPA PROBE FORCE qPCR Kit
Agilent Technologies Launches AriaMx System

7. RECENT INDUSTRY ACTIVITY
RainDance and Bio-Rad Ink Definitive Acquisition Agreement
Curetis Buys Gyronimo Platform from Carpegen and Systec
QIAGEN Takes Over Exiqon
LGC Takes Over Douglas Scientific
Bio-Rad Secures CE Marking for QX200™ Droplet Digital™ PCR System
Roche to Take Over Kapa Biosystems
LGC to Acquire Biosearch
Thermo Fisher Scientific Completes Take Over of Life Technologies

8. FOCUS ON SELECT PLAYERS
Agilent Technologies, Inc. (USA)
Becton, Dickinson and Company (USA)
BioFire Diagnostics, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Cepheid (USA)
Eppendorf AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Fluidigm Corporation (USA)
Promega Corporation (USA)
QIAGEN N.V. (Netherlands)
RainDance Technologies, Inc. (USA)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE
Table 12: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 13: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 14: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Analytics by Product Category
Table 15: World Recent Past, Current & Future Analysis for qPCR and dPCR Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 16: World Historic Review for qPCR and dPCR Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 17: World 14-Year Perspective for qPCR and dPCR Reagents by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for qPCR and dPCR Instruments by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 19: World Historic Review for qPCR and dPCR Instruments by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for qPCR and dPCR Instruments by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Analysis by Product Segment
Table 21: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Product Segment
qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Product Segment
qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Product Segment
Percentage Breakdown of Revenues for qPCR and dPCR Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysis for qPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 25: World Historic Review for qPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for qPCR Instrumentation and Reagents by Product Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for dPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 28: World Historic Review for dPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for dPCR Instrumentation and Reagents by Product Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Analytics by End-Use
Table 30: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by End-Use Segment
Educational/ Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 31: World Historic Review for qPCR and dPCR Instrumentation and Reagents by End-Use Segment
Educational/Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for qPCR and dPCR Instrumentation by End-Use Segment
Percentage Breakdown of Revenues for Educational/Research, Testing Laboratories and Pharma Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current and Future Analysis
qPCR Vs. dPCR Instrumentation is the US
Cancer Stats
Cancer Incidence Statistics
Table 33: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)
Table 34: Cancer Related Deaths by Gender in the US (2017E) (includes corresponding Graph/Chart)
Table 35: New Cancer Cases by State in the US (2017E) (includes corresponding Graph/Chart)
Cancer Mortality Statistics
Table 36: Cancer Related Deaths in the US by Gender and Body Site: 2017 (includes corresponding Graph/Chart)
Table 37: Number of Deaths Related to Major Types of Cancer in US by State: 2017E (includes corresponding Graph/Chart)
Competitive Landscape
Product Introductions
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 38: The US Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: The US Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 40: The US 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current and Future Analysis
Cancer Statistics in Canada
Table 41: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
Table 42: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart)
Table 43: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart)
Table 44: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)
Funglyn Biotech, Inc.
A Key Player
B.Market Analytics
Table 45: Canadian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 46: Canadian Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 47: Canadian 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current and Future Analysis
Product Launch
Takara Bio, Inc.
A Key Player
B.Market Analytics
Table 48: Japanese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 49: Japanese Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 50: Japanese 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current and Future Analysis
PCR Reagents in Europe: An Overview
qPCR Competitive Landscape
Strategic Corporate Development
B.Market Analytics
Table 51: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 52: European Historic Review for qPCR and dPCR Instrumentation by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 53: European 14-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 54: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 55: European Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 56: European 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current and Future Analysis
Product Launch
B.Market Analytics
Table 57: French Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 58: French Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 59: French 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current and Future Analysis
Product Launch
Strategic Corporate Development
Eppendorf Ag
A Key German Player
B.Market Analytics
Table 60: German Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 61: German Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 62: German 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 63: Italian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 64: Italian Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 65: Italian 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
Market Analysis
Table 66: The UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 67: The UK Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 68: The UK 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
A.Market Analysis
Current and Future Analysis
Product Launches
Strategic Corporate Development
Key Players
B.Market Analytics
Table 69: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 70: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 71: Rest of Europe 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
Market Analysis
Table 72: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region
China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 73: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region
China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 74: Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region
Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 75: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 76: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 77: Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5a. CHINA
Market Analysis
Table 78: Chinese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 79: Chinese Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 80: Chinese 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
5b. REST OF ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
India
Market Overview
Traditional PCRs Still Rule the Indian PCR Market
Table 81: Indian PCR Systems Market by Type (2017E): Percentage Breakdown of Market Value and Volume for RT PCRs and Traditional PCRs (includes corresponding Graph/Chart)
Table 82: Indian PCR Systems Market by End-Use Industry (2017E): Percentage Breakdown of Sales for Biopharma, Diagnostics and Life Sciences & Biotech (includes corresponding Graph/Chart)
B.Market Analytics
Table 83: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 84: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 85: Rest of Asia-Pacific 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA
Market Analysis
Table 86: The Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 87: The Middle East Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 88: The Middle East 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. LATIN AMERICA
Market Analysis
Table 89: Latin American Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 90: Latin American Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 91: Latin American 14-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 36 (including Divisions/Subsidiaries 38)

• The United States (22)
• Canada (1)
• Japan (1)
• Europe (13)
  • France (1)
  • Germany (5)
  • The United Kingdom (1)
  • Rest of Europe (6)
• Asia-Pacific (Excluding Japan) (1)